drugset / Trial / NCT01229085

Efficacy Study of the Combination Mometasone + Salicylic Acid in Patients With Psoriasis

NCT01229085

Phase 3 Completed 71 enrolled Azidus Brasil
Non-randomizedSingle-groupOpen-labelTreatment

Summary

To evaluate the efficacy of the combination of mometasone furoate 0.1% and Salicylic Acid 5% in patients of both sexes who presented clinical symptoms of psoriasis of mild to moderate.

Timeline

Start
2006-09
Primary completion
2007-10
Completion
2007-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Mometasone Other / unclassified 0.1 % Topical
Subject salicylic acid Small molecule 5 % Topical

Indications